Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-30T03:31:43.140Z Has data issue: false hasContentIssue false

The RNA editing patterns are different in blood of euthymic and depressed bipolar patients

Published online by Cambridge University Press:  19 July 2023

M. Hayashi*
Affiliation:
UNIFESP, SAO PAULO, Brazil
N. Salvetat
Affiliation:
ALCEDIAG/Sys2Diag, Montpellier, France
C. Cayzac
Affiliation:
ALCEDIAG/Sys2Diag, Montpellier, France
F. J. Checa-Robles
Affiliation:
ALCEDIAG/Sys2Diag, Montpellier, France
C. Lozano
Affiliation:
ALCEDIAG/Sys2Diag, Montpellier, France
J.-D. Abraham
Affiliation:
ALCEDIAG/Sys2Diag, Montpellier, France
B. Dubuc
Affiliation:
ALCEDIAG/Sys2Diag, Montpellier, France
S. Mereuze
Affiliation:
ALCEDIAG/Sys2Diag, Montpellier, France
J. V. Nani
Affiliation:
UNIFESP, SAO PAULO, Brazil
F. Molina
Affiliation:
ALCEDIAG/Sys2Diag, Montpellier, France
E. Brietske
Affiliation:
Queen’s University School of Medicine, Kingston, Canada
D. Weissmann
Affiliation:
ALCEDIAG/Sys2Diag, Montpellier, France
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Bipolar disorder (BD) is a severe mental disorder associated with functional impairment, high disability and premature mortality. Modifications of editing in mRNA of serotonin receptor subtype 2C (5-HTR2c) was reported by us in depressed suicide decedents. We have also identified a panel of RNA editing-based blood biomarkers for the diagnosis of BD, which also allowed to discriminate unipolar depression from BD with high sensivity and specificity.

Objectives

Herein, aiming to confirm the diagnostic value of this panel, a new cohort of BD patients was recruited in Brazil.

Methods

This study is based on the analysis of 47 control patients (CTRL) compared to 40 patients with bipolar disorder (BD). BD patients (BP) were classified into 4 subgroups: euthymic (BP_EUT, n = 17), depressive (BP_DEP, n = 11), manic/hypomanic (BP_HM, n = 7) and mixed (BP_MIX, n = 5). The diagnostic value of a panel of RNA editing-based blood biomarkers for the diagnosis of BD, which includes a set of eight genes, namely PDE8A, CAMK1D (calcium/calmodulin-dependent protein kinase type 1D); GAB2 (growth factor receptor bound protein 2-associated protein 2); IFNAR1 (interferon alpha/beta receptor 1); KCNJ15 (ATP-sensitive inward rectifier potassium channel 15); LYN (tyrosine-protein kinase Lyn); MDM2 (E3 ubiquitin-protein ligase Mdm2); PRKCB (protein kinase C beta type), which was able to discriminate unipolar depression from BD with high sensivity and specificity, was confirmed here by testing an independent cohort of patients suffering from BD recruited in a well-known genetic admixed ancestry population, which is typical in South America, more specifically in Brazil.

Results

We identified new combinations allowing a clear discrimination of euthymic versus depressed bipolar patients, and euthymic versus healthy controls, confirming that RNA editing is a key mechanism in the physiopathology of mental disorders, in particular in BD.

Conclusions

In conclusion of this study, we confirm that RNA editing is a key mechanism in the physiopathology of mental disorders in general, and in BD in particular, and that measuring changes in this mechanism at the peripheral level allowed us to stratify BD patients not only with respect to their symptomatology, but also with respect to the pathophysiology, thus paving the way for personalised medicine in psychiatry.

Disclosure of Interest

None Declared

Type
Abstract
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.